Demis Hassabis, cofounder of DeepMind and 2024 Nobel Laureate, talks to Fortune about his AI drug discovery startup, Isomorphic Labs.

金融时报消息，总部位于英国伦敦的 Isomorphic Labs 宣布完成6 亿美元融资。本次由 Thrive Capital 领投，现有投资者G谷歌的母公司Alphabet、GV也进行了追加投资。这笔资金将用于进一步开发其人工智能驱动的药物设计技术 ...

在科技飞速发展的今天，药物研发已进入了一个全新的时代。尤其在人工智能 (AI)的帮助下，各种药物的诞生与设计变得更加高效与精准。你是否已经听说过Isomorphic Labs？当我们谈论下一代的制药技术时，这家公司就像是一道闪亮的光辉，吸引了众多目光！就在本周一，Isomorphic Labs宣布成功融资6亿美元，不禁让我们对这波资金注入感到惊讶与期待！

There has been much speculation over how AI will help with healthcare, but some experts believe it can have a dramatic impact ...

Demis Hassabis, cofounder of DeepMind and 2024 ... AlphaFold’s success would pave the way for Isomorphic Labs, a spinoff focused on AI-driven drug discovery. Isomorphic was founded in 2021, ...

Isomorphic Labs, an Alphabet-backed AI biotech firm, raised $600M to boost its AI drug design engine, expand clinical ...

Isomorphic Labs, the AI drug-discovery platform that was spun out of Google's DeepMind in 2021, has raised external capital ...

The system would go on to win a Nobel Prize in chemistry. It also helped Murdoch, and Isomorphic's founder Demis Hassabis, decide on an ultimate goal: to "solve all disease" through AI-powered ...